Alnylam Pharmaceuticals, Inc. logo ALNY - Alnylam Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 39
HOLD 12
SELL 1
STRONG
SELL 0
| PRICE TARGET: $445.67 DETAILS
HIGH: $530.00
LOW: $351.00
MEDIAN: $445.50
CONSENSUS: $445.67
UPSIDE: 49.83%

Profitability Ratios

Ratio Value
GP Margin 81.8%
EBIT Margin 13.5%
EBITDA Margin 15.0%
Operating Margin 13.5%
Pretax Margin 8.7%
Cont. Ops Margin 8.4%
Net Margin 8.4%
Bottom Line Margin 8.4%

Liquidity Ratios

Ratio Value
Current Ratio 2.76
Quick Ratio 2.71
Solvency Ratio 0.088
Cash Ratio 1.13

Valuation Ratios

Ratio Value
Price/Earnings
166.04
Peers avg: 26.9
PEG Ratio -0.79
Forward PEG -0.79
Price/Book 66.01
Price/Sales 14.03
Price/FCF 111.94
Price/Op Cash Flow 99.40

Debt Ratios

Ratio Value
Debt/Assets 0.2574
Debt/Equity 1.6199
Debt/Capital 0.6183
Long-Term Debt/Capital 0.5608
Financial Leverage 6.29

Cash Flow Ratios

Ratio Value
Working Capital Turnover 1.58
Operating Cash Flow Ratio 0.357
Operating Cash Flow/Sales 14.1%
Free Cash Flow/Operating Cash Flow 88.8%

Coverage Ratios

Ratio Value
Debt Service Coverage 2.17
Interest Coverage 1.9854
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage 0.41
Capital Expenditure Coverage 8.93
Dividend + Capital Expenditure Coverage 8.93

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 28.35
EPS 2.395
Debt/Share 11.6868
Cash/Share 22.20
Book Value/Share 6.02
Tangible BV/Share 6.02
Equity/Share 6.02
Operating Cash Flow/Share 4.000
Capital Expenditure/Share 0.448
FCF/Share 3.552

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.971
Earnings Before Tax/EBIT 0.644
Price/Fair Value 66.01
Debt/Market Cap 0.0193
Effective Tax Rate 2.9%
Enterprise Value Multiple 92.81